======= GAK ======= == Gene Information == * **Official Symbol**: GAK * **Official Name**: cyclin G associated kinase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2580|2580]] * **UniProt**: [[https://www.uniprot.org/uniprot/O14976|O14976]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GAK&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GAK|Open PubMed]] * **OMIM**: [[https://omim.org/entry/602052|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Associates with cyclin G and CDK5. Seems to act as an auxilin homolog that is involved in the uncoating of clathrin- coated vesicles by Hsc70 in non-neuronal cells. Expression oscillates slightly during the cell cycle, peaking at G1. {ECO:0000269|PubMed:10625686}. |Pkinase Tyr| |Pkinase| |PTEN C2| |DnaJ| |clathrin-coated pit assembly| |synaptic vesicle uncoating| |clathrin coat disassembly| |vesicle uncoating| |Golgi to lysosome transport| |Golgi to vacuole transport| |clathrin-dependent endocytosis| |protein localization to Golgi apparatus| |cyclin binding| |chaperone cofactor-dependent protein refolding| |protein depolymerization| |de novo posttranslational protein folding| |clathrin binding| |de novo protein folding| |synaptic vesicle endocytosis| |presynaptic endocytosis| |synaptic vesicle recycling| |endoplasmic reticulum organization| |chaperone-mediated protein folding| |presynapse| |post-Golgi vesicle-mediated transport| |chaperone binding| |lysosomal transport| |synaptic vesicle cycle| |vesicle-mediated transport in synapse| |Golgi organization| |cellular protein complex disassembly| |vesicle| |vacuolar transport| |cytosolic transport| |negative regulation of neuron projection development| |negative regulation of cell projection organization| |protein localization to plasma membrane| |negative regulation of neuron differentiation| |protein localization to cell periphery| |protein folding| |receptor-mediated endocytosis| |protein-containing complex disassembly| |negative regulation of neurogenesis| |negative regulation of nervous system development| |negative regulation of cell development| |protein serine/threonine kinase activity| |Golgi vesicle transport| |cellular component disassembly| |focal adhesion| |endomembrane system organization| |protein localization to membrane| |regulation of neuron projection development| |endocytosis| |regulation of neuron differentiation| |import into cell| |intracellular membrane-bounded organelle| |regulation of plasma membrane bounded cell projection organization| |perinuclear region of cytoplasm| |negative regulation of cellular component organization| |regulation of cell projection organization| |negative regulation of cell differentiation| |protein localization to organelle| |regulation of neurogenesis| |membrane organization| |regulation of nervous system development| |regulation of cell development| |negative regulation of developmental process| |protein phosphorylation| |Golgi apparatus| |negative regulation of multicellular organismal process| |phosphorylation| |cell cycle| |ATP binding| |intracellular transport| |generation of neurons| |cellular protein localization| |cellular macromolecule localization| |neurogenesis| |regulation of cell differentiation| |establishment of localization in cell| |protein-containing complex subunit organization| |vesicle-mediated transport| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp517|Quercetin 20μM R08 exp517]]|-3.44| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-3.21| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-3.17| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-3.16| |[[:results:exp54|Taxol 0.002μM R01 exp54]]|-3.11| |[[:results:exp159|Docetaxel 0.001 to 0.002μM on day4 R04 exp159]]|-3.03| |[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|-2.86| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|-2.79| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|-2.74| |[[:results:exp485|GSK626616 14μM R08 exp485]]|-2.73| |[[:results:exp460|BML-284 0.09μM R08 exp460]]|-2.57| |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.56| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|-2.54| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.42| |[[:results:exp290|LLY-283 2.6μM R06 exp290]]|-2.35| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|-2.29| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|-2.25| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-2.16| |[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|-2.15| |[[:results:exp58|UM131593 0.1μM R01 exp58]]|-2.11| |[[:results:exp46|HMS-I1 1μM R01 exp46]]|-2.1| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2.08| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-2.03| |[[:results:exp502|Milciclib 2μM R08 exp502]]|-1.96| |[[:results:exp125|GSK461364A 0.005μM R03 exp125]]|-1.95| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-1.93| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.91| |[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|-1.82| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-1.81| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-1.8| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|-1.77| |[[:results:exp532|TIC10 10μM R08 exp532]]|-1.76| |[[:results:exp210|LB-100 2μM R05 exp210]]|-1.75| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-1.74| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-1.72| |[[:results:exp275|Citral 75μM R06 exp275]]|-1.7| |[[:results:exp187|proTAME 5μM R04 exp187]]|-1.7| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|1.85| |[[:results:exp222|Betulinic acid 10 to 15μM on day4 R05 exp222]]|2.08| ^Gene^Correlation^ |[[:human genes:t:tacc3|TACC3]]|0.648| |[[:human genes:d:dlgap5|DLGAP5]]|0.585| |[[:human genes:g:gsg2|GSG2]]|0.472| |[[:human genes:g:gtse1|GTSE1]]|0.468| |[[:human genes:a:aspm|ASPM]]|0.447| |[[:human genes:c:cltc|CLTC]]|0.438| |[[:human genes:k:kif18a|KIF18A]]|0.414| |[[:human genes:b:bub1|BUB1]]|0.403| Global Fraction of Cell Lines Where Essential: 20/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|2/28| |bone|0/26| |breast|1/33| |central nervous system|0/56| |cervix|0/4| |colorectal|1/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|1/75| |lymphocyte|1/16| |ovary|1/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|1/1| |skin|1/24| |soft tissue|1/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2114 * **Expression level (log2 read counts)**: 6.87 {{:chemogenomics:nalm6 dist.png?nolink |}}